Sindbis virus outbreak and evidence for geographical expansion in Finland, 2021.

Alphavirus Infections / diagnosis Disease Outbreaks Finland / epidemiology Geography Humans Sindbis Virus
Finland Pogosta disease Sindbis virus mosquito-borne virus outbreak

Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
08 2022
Historique:
entrez: 5 8 2022
pubmed: 6 8 2022
medline: 9 8 2022
Statut: ppublish

Résumé

Sindbis virus (SINV) caused a large outbreak in Finland in 2021 with 566 laboratory-confirmed human cases and a notable geographical expansion. Compared with the last large outbreak in 2002, incidence was higher in several hospital districts but lower in traditionally endemic locations in eastern parts of the country. A high incidence is also expected in 2022. Awareness of SINV should be raised in Finland to increase recognition of the disease and prevent transmission through the promotion of control measures.

Identifiants

DOI: 10.2807/1560-7917.ES.2022.27.31.2200580 PMID: 35929430 PMC: PMC9358406
pubmed: 35929430
doi: 10.2807/1560-7917.ES.2022.27.31.2200580
pmc: PMC9358406
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ErratumIn

Références

Vector Borne Zoonotic Dis. 2020 Nov;20(11):843-849
pubmed: 32898458
Rev Med Virol. 2016 Jul;26(4):221-41
pubmed: 26990827
Int J Environ Res Public Health. 2021 Jul 01;18(13):
pubmed: 34281003
J Infect Dis. 2011 Aug 1;204(3):459-66
pubmed: 21742846
Virol J. 2014 Oct 21;11:183
pubmed: 25330992
Vector Borne Zoonotic Dis. 2008 Jun;8(3):303-11
pubmed: 18380591
Rheumatology (Oxford). 2000 Nov;39(11):1272-4
pubmed: 11085809
Epidemiol Infect. 2013 Sep;141(9):1857-66
pubmed: 23158410
Emerg Microbes Infect. 2018 Feb 7;7(1):13
pubmed: 29410416
Epidemiol Infect. 2002 Oct;129(2):335-45
pubmed: 12403109
Scand J Infect Dis. 2008;40(2):167-73
pubmed: 17852949
J Infect Dis. 2005 Jun 1;191(11):1820-9
pubmed: 15871114
Emerg Infect Dis. 2018 Jun;24(6):1141-1142
pubmed: 29781426
Emerg Infect Dis. 2004 May;10(5):889-94
pubmed: 15200824
Emerg Infect Dis. 2008 Jan;14(1):41-7
pubmed: 18258075

Auteurs

Maija T Suvanto (MT)

Department of Virology, University of Helsinki, Helsinki, Finland.
Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.

Ruut Uusitalo (R)

Department of Virology, University of Helsinki, Helsinki, Finland.
Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.
Department of Geosciences and Geography, University of Helsinki, Helsinki, Finland.

Eveline Otte Im Kampe (E)

Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland.
ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.

Tytti Vuorinen (T)

Institute of Biomedicine, University of Turku, Turku, Finland.
Department of Clinical Microbiology, Turku University Hospital, Turku, Finland.

Satu Kurkela (S)

HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Olli Vapalahti (O)

Department of Virology, University of Helsinki, Helsinki, Finland.
Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.
HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Timothée Dub (T)

Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland.

Eili Huhtamo (E)

Department of Virology, University of Helsinki, Helsinki, Finland.
Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.

Essi M Korhonen (EM)

Department of Virology, University of Helsinki, Helsinki, Finland.
Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Infections à Togaviridae › Infections à alphavirus › Sindbis virus outbreak and evidence for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Sindbis virus outbreak and evidence for...
questionsmedicales.fr › Régions géographiques › Europe › Pays nordiques et scandinaves › Finlande › Sindbis virus outbreak and evidence for...
questionsmedicales.fr › Disciplines des sciences naturelles › Sciences de la Terre › Géographie › Sindbis virus outbreak and evidence for...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Sindbis virus outbreak and evidence for...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Togaviridae › Alphavirus › Virus Sindbis › Sindbis virus outbreak and evidence for...